-
New flavors, creations push beer toward high-end
Higher-end products are where the beer category is headed. “We’re seeing a lot of high-end segments continuing to steer the ship,” said Dan Wandel, SVP at IRI. “We’re seeing higher-priced products driving the category.”
(For the full category review, including sales data, click here.)
-
Biosimilars market in Europe provides insights to U.S.
When it comes to laws and regulations, what happens in Europe stays in Europe generally, and doesn’t have much bearing on the United States. But a recent win in Europe for U.S. drug maker Hospira could have some implications for the United States as well.
Last month, the company — which specializes in making generic injectable drugs — announced that European Union regulators had approved the continent’s first biosimilar monoclonal antibody.